The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol

The Ndovu study will address critical gaps in the management of DTG failure including the emergence, determinants and implications of DTG resistance. Further, it will evaluate the optimal ART regimens to use in the setting of DTG resistance in adults and children.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-03-13
DOI
https://doi.org/10.1371/journal.pone.0330792
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol

Daniel J. Grint, Charles Opondo, Dalton C. Wamalwa, Victor Omodi et al.
PLoS ONE
HIV/AIDS drug development and treatment
article

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol

Daniel J. Grint, Charles Opondo, Dalton C. Wamalwa, Victor Omodi, Irene Ayakaka, Patricia Munseri, Lisa Abuogi, James Wagude, Patrick Amoth, Edwin T. Kamau, Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, Edwin Otieno, Andrew Mulwa, AnneMarie Macharia, Leonard King’wara, on behalf of the ESUR Prostate MRI Working Group, Patricia Ramgi, Raquel Matavele Chissumba, Niklaus Labhardt, Rena Patel, Nalia Ismael, Muhammad Bakari
article en

Abstract

The Ndovu study will address critical gaps in the management of DTG failure including the emergence, determinants and implications of DTG resistance. Further, it will evaluate the optimal ART regimens to use in the setting of DTG resistance in adults and children.

PLoS ONEVol. 21(3)
University of Nairobi (KE), University of British Columbia (CA), Muhimbili University of Health and Allied Sciences (TZ), University Hospital of Basel (CH), Kenyatta National Hospital (KE), University of Alabama at Birmingham (US), London School of Hygiene & Tropical Medicine (GB), National Aids Control Council (KE), Ministry of Health (KE), Instituto Nacional de Saúde (MZ), Community-Campus Partnerships for Health (US), Instituto de Investigação Agrária de Moçambique (MZ), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 25%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.